Citations

Clear

4 citation(s) found for "Cao, Jiang".

Portable Device Improves the Detection of Atrial Fibrillation After Ablation
Huang, Songqun , Liu, Chao , Qin, Aihong, Dong, Shaohua, Xing, Wenhui , Guo, Zhifu , Huang, Xinmiao, Cha, Yong‐Mei , Cao, Jiang, Cha, Yongmei, Zhao, Teng , Yuan, Binhang

Mayo Clinic

International Heart Journal | July 16, 2021 | Volume: 62 | Issue: 4 | Pages: 786-791

10.1536/ihj.21-067 | PMID 34276021 Get It

The portable device improves the detection of atrial fibrillation after ablation
Huang, Songqun , Liu, Chao , Qin, Aihong, Dong, Shaohua, Xing, Wenhui , Guo, Zhifu , huang, xin-miao, Cha, Yong‐Mei , Zhao, Teng , Yuan, Binhang , huang, xin-miao, Cao, Jiang

Mayo Clinic

No container title available | August 4, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159657690.03276294 Get It

Background: Asymptomatic recurrences of atrial fibrillation (AF) are common after ablation of AF. Objective: We aimed to analyze the performance of the mobile ECG device using artificial intelligence (AI) algorithm in detection of AF after ablation. Method: A randomized controlled trial of AF screening using a handheld single-lead ECG monitor (BigThumb®) or a traditional follow-up strategy was conducted in patients with non-valvular AF after catheter ablation. Consecutive patients were randomized to either BigThumb Group (BT Group) or Traditional Follow-up Group (TF Group). Monitoring data was collected and analyzed. The ECGs collected by BigThumb were compared using the automated AF detection algorithm, AI algorithm and cardiologists’ manual review. Subsequent changes in adherence on oral anticoagulation of patients were also recorded. Result: We studied 218 patients (109 in BT Group, 109 in TF Group). After a follow-up of 345.4±60.2 days, AF-free survival rate was 64.2% in BT Group and 78.9% in TF Group (P=0.0163), with more adherence on oral anticoagulation in BT Group (P=0.0052). The participants in the BT Group recorded 26133 ECGs during the follow-up, among which 3299 (12.6%) were diagnosed as AF by cardiologists’ manual review. The sensitivity and specificity of the AI algorithm were 94.4% and 98.5% respectively, which are significantly higher than the automated AF detection algorithm (90.7% and 96.2%). Conclusion: We found that follow-up after AF ablation using BigThumb leads to a more frequent detection of AF recurrence and more adherence on oral anticoagulation. Artificial intelligence algorithm improves the accuracy of ECG diagnosis.
Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves
Huang, Xin-Miao, Fu, Hai-xia, Zhong, Li , Cao, Jiang, Asirvatham, Samuel J. , Sohail, M. Rizwan , Nishimura, Rick A., Greason, Kevin L. , Suri, Rakesh M. , Friedman, Paul A. , Cha, Yong‐Mei , Baddour, Larry M. , Nkomo, Vuyisile T. , Suri, Rakesh M. , Asirvatham, Samuel J , Sohail, M Rizwan

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 15, 2016 | Volume: 9 | Issue: 9 | Pages: No page available

10.1161/circep.116.004188 | PMID 27635069 Get It

Background— Lead-related or valve-related endocarditis can complicate cardiovascular implantable electronic device (CIED) infection in patients with both CIED and prosthetic valves. The objective of this study was to determine the outcomes of transvenous lead extraction for CIED infection in patients with prosthetic valves. Methods and Results— We retrospectively screened 794 transvenous lead extraction procedures, between September 1, 2001 and August 31, 2012, at Mayo Clinic to identify patients with prosthetic valves who underwent lead extraction for infection. Demographic, clinical, and follow-up characteristics were analyzed. In total, 51 patients (6%) met the study inclusion criteria, of whom 20 had pocket infection and 31 had lead-related or valve-related, or both, endocarditis or bloodstream infection (mean age, 67 [18] years). Staphylococcal species were the most common pathogens, including Staphylococcus aureus in 20 cases (39%) and coagulase-negative staphylococci in 19 cases (37%). Overall, 127 transvenous leads (median lead age, 52 months) were extracted. Of these leads, 123 (97%) were removed completely. The in-hospital mortality rate was 9.8%; no deaths were attributable to the extraction procedure. Ninety-five percent of patients who survived had no evidence of recurrent device-related or valve-related infection. Conclusions— Transvenous lead extraction seems safe and curative in patients with CIED infection and prosthetic valves. Cure of infection can be achieved in the majority of patients with complete CIED removal and antimicrobial therapy and without valve surgery.
Outcomes of Lead Revision for Myocardial Perforation After Cardiac Implantable Electronic Device Placement
Huang, Xinmiao , Fu, Hai‐Xia , Zhong, Li , Osborn, Michael J., Asirvatham, Samuel J. , Sinak, Lawrence J., Cao, Jiang, Friedman, Paul A. , Cha, Yong‐Mei , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | May 26, 2014 | Volume: 25 | Issue: 10 | Pages: 1119-1124

10.1111/jce.12457 | PMID 24863054 Get It

Percutaneous Lead Revision for Cardiac PerforationIntroductionCardiac perforation is an infrequent but potentially life‐threatening complication associated with placement of a cardiac implantable electronic device (CIED). The objective of this study was to determine the outcomes of percutaneous lead revision in patients who had lead perforation of the myocardium after CIED placement.Methods and ResultsWe reviewed records of 1,458 patients who underwent CIED lead extraction or repositioning. Of these, 31 (2.1%) had the procedure performed for lead perforation as a complication of CIED placement. Demographic, clinical, and follow‐up characteristics of the patients were analyzed. Mean (SD) patient age was 65 (23) years. Cardiac perforation was detected within 24 hours after implantation in 9 patients, within 1 month in 17, and greater than 1 month in 5. Pericardiocentesis was performed with a pigtail drainage catheter in place before the lead revision in 17 patients (55%) who had pericardial effusion, with or without hemodynamic compromise. All culprit leads were successfully managed with percutaneous lead removal (n = 3 [10%]), new lead placement (n = 12 [38%]), or lead repositioning (n = 16 [52%]). Of the 17 patients with pericardiocentesis before the reoperation, none had tamponade develop; in contrast, 3 of the remaining 14 patients had tamponade develop and required urgent pericardiocentesis. All patients survived without requiring open chest surgery.ConclusionPercutaneous removal or repositioning of the perforating lead is feasible and appears effective. Placement of a prophylactic pericardial drain catheter may reduce the incidence of urgent pericardiocentesis during or after a procedure.